FundedIQ
Biotechnology

Microcaps: Funding, Investors & Team (Sep 2026)

Microcaps has created an innovative technology using microfluidics to produce accurate microcapsules and microparticles on a large scale. Their goal is to offer a fully automated production facility for encapsulation that allows for precise control of size, dosing, and stability of the particles.

www.microcaps.ch LinkedIn Zürich, Switzerland 11-50 employees
Total raised
$16.0M
Rounds
2
Latest
Series A
Jun 2024

Microcaps has raised $16.0M across 2 funding rounds on record, the most recent a Series A of $10.4M announced in Jun 2024.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Microcaps Company Profile and Key Stats

Total funding raised
$16.0M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series A
$10.4M in Jun 2024
Employees
11-50
reported band
Headquarters
Zürich, Switzerland

Latest funding round on record: Jun 2024.

Microcaps Funding Rounds

Date
Round
Amount
Series A
$10.4M
Seed
$5.6M

Microcaps raised $5.6M in a Seed announced in Jan 2021.

3.4 years later, a Series A of $10.4M was announced in Jun 2024.

Microcaps Founders and Leadership Team

Name
Role
Contact
Michael Hagander
Founder
Locked
Alessandro Ofner
CEO
Locked

Contact details for the Microcaps team: 2 of 2 have an email address on file.

Start 14-day free trial →

Microcaps Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
881
$3.8M
8,378
$15M

Microcaps' latest round of $10.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Microcaps in Biotechnology and Zürich

Companies Similar to Microcaps

Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…

Series A $40.0M

At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…

Pre-Seed $3.0M

compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…

Undisclosed round $1.2M

MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…

Undisclosed round $200M

Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…

Undisclosed round $490k

Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…

Pre-Seed $120k

Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…

Undisclosed round $1.1M

AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…

Undisclosed round $4.0M

AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…

Undisclosed round $1.2M

Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…

Undisclosed round $1.4M

MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…

Undisclosed round $10.2M

Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…

Seed $7.5M

Microcaps Funding FAQs

What does Microcaps do?

Microcaps has created an innovative technology using microfluidics to produce accurate microcapsules and microparticles on a large scale. Their goal is to offer a fully automated production facility for encapsulation that allows for precise control of size, dosing, and stability of the particles.

How much funding has Microcaps raised?

Microcaps has raised $16.0M across 2 rounds on record. The most recent is a Series A of $10.4M announced in Jun 2024.

When did Microcaps last raise funding?

Microcaps' most recent funding round on record is a Series A of $10.4M, announced in Jun 2024.

Who founded Microcaps?

FundedIQ lists Michael Hagander (Founder) at Microcaps.

Who is the CEO of Microcaps?

Alessandro Ofner is listed as CEO at Microcaps.

Where is Microcaps headquartered?

Microcaps is based in Zürich, Zurich, Switzerland.

How many employees does Microcaps have?

Microcaps is in the 11-50 employee band.

How does Microcaps' funding compare to other Biotechnology startups?

Microcaps' latest round of $10.4M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Microcaps Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Microcaps is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.